Plasma tumour and metabolism related biomarkers differentiate PAH from HFpEF-PH may improve long-term prognosis

Int J Cardiol. 2022 Jan 15:347:64-65. doi: 10.1016/j.ijcard.2021.11.024. Epub 2021 Nov 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers
  • Heart Failure* / diagnosis
  • Humans
  • Neoplasms* / diagnosis
  • Prognosis
  • Stroke Volume

Substances

  • Biomarkers